Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Borderline Personality Disorder01:25

Borderline Personality Disorder

Borderline Personality Disorder is a complex and multifaceted mental health condition characterized by pervasive instability in interpersonal relationships, self-image, emotions, and impulse control. This instability manifests in extreme emotional reactions, fear of abandonment, and self-destructive behaviors. The disorder significantly impacts daily functioning, often leading to distress in both personal and professional domains.
Genetic and Environmental Contributions
Borderline Personality...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterizing treatment initiation with central nervous system-active polypharmacy among adults with dementia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Supporting older-adult behavioral health: building the first state Center of Excellence for Behavioral Health and Aging.

Health affairs scholar·2025
Same author

Long-Term Patterns of Alcohol Use in Older Different-Sex Couples: Concordant Drinking Appears Initially Protective but Predicts Declines in Health Over Time.

Journal of studies on alcohol and drugs·2025
Same author

Adaptive interventions for alcohol misuse and violent behaviors among adolescents and emerging adults in the emergency department: Outcomes from a sequential multiple assignment randomized controlled trial.

Drug and alcohol dependence·2025
Same author

An Educational Intervention to Promote Central Nervous System-Active Deprescribing in Dementia: A Pilot Study.

Drugs & aging·2025
Same author

Clinician contributions to central nervous system-active polypharmacy among older adults with dementia in the United States.

Journal of the American Geriatrics Society·2024
Same journal

Catatonia Associated with Psychosis: A Retrospective Study of 164 Inpatients.

Psychopharmacology bulletin·2026
Same journal

Escitalopram-Induced Spasmodic Torticollis in an Early Psychosis Service: A Case Report.

Psychopharmacology bulletin·2026
Same journal

Beyond Exposure: Standardizing Buprenorphine Training in Pain Medicine Fellowship.

Psychopharmacology bulletin·2026
Same journal

Association of CBC-Derived Indices of Inflammation with Response to Glecaprevir/Pibrentasvir for PTSD.

Psychopharmacology bulletin·2026
Same journal

When Care Becomes Dangerous: Patient Assaults Against Physicians.

Psychopharmacology bulletin·2026
Same journal

Efficacy and Safety of Centanafadine in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Psychopharmacology bulletin·2026
See all related articles

Related Experiment Video

Updated: Jun 6, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Why do persons with bipolar disorder stop their medication?

Kavi K Devulapalli1, Rosalinda V Ignacio, Peter Weiden

  • 1Case Western Reserve University, School of Medicine, Cleveland, OH, USA.

Psychopharmacology Bulletin
|December 15, 2010
PubMed
Summary
This summary is machine-generated.

Bipolar disorder patients not adhering to medication believe it is unnecessary or offers no daily benefit. Fear of relapse strongly predicts adherence, highlighting the need for attitude assessments to improve treatment outcomes.

Related Experiment Videos

Last Updated: Jun 6, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Area of Science:

  • Psychiatry and Behavioral Sciences
  • Pharmacology and Therapeutics

Background:

  • Non-adherence to maintenance medication is a significant challenge in managing bipolar disorder.
  • This issue negatively impacts treatment outcomes for a substantial number of patients.

Purpose of the Study:

  • To identify key adherence attitudes influencing medication non-adherence in bipolar disorder patients.
  • To explore the specific reasons behind adherence and non-adherence behaviors in this population.

Main Methods:

  • A subsample of 27 bipolar disorder patients exhibiting non-adherent behavior (missing ≥30% medication) was selected from a larger cohort.
  • The Rating of Medication Influences (ROMI) scale assessed adherence attitudes, with logistic regression analyzing predictors of non-adherence.

Main Results:

  • Belief that medications are unnecessary was the strongest predictor of non-adherence (p < 0.0001).
  • Other significant factors for non-adherence included perceived lack of daily benefit, appearance changes, and interference with life goals.
  • Fear of relapse was the strongest predictor of adherence (p = 0.0017).

Conclusions:

  • Bipolar disorder patients who are non-adherent differ significantly in their attitudes towards medication compared to adherent patients.
  • Utilizing tools like the ROMI scale can help clinicians tailor interventions to improve medication adherence.